This is a preview of subscription content, log in via an institution to check access.
Reference
Eisai. Eisai Announces That it Will Suspend Temporarily Commercial Distribution of Innovative Antiepileptic Drug Fycompa (Perampanel) in Germany. Media Release : 24 Jun 2013
Rights and permissions
About this article
Cite this article
G-BA's decision leads Eisai to suspend perampanel distribution. PharmacoEcon Outcomes News 682, 11 (2013). https://doi.org/10.1007/s40274-013-0556-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0556-6